Under the wave of "AI for Science," molecular research in laboratories is undergoing a paradigm shift from "digitization" to "intelligentization."

Recently, the tech company MetaNovas, which is among the first globally to commercialize AI-designed new molecular materials, announced that it has successfully completed two rounds of financing: Series A+ and Series A++. The round was backed by a stellar lineup of investors, including Fuhua Capital, Hillhouse Capital, and the Kangaroo Mom Group, all of which are involved in the consumer health industry.

Breaking the "Heavy on Generation, Light on Implementation": Let AI Molecules Leave the Lab

For a long time, AI in the field of molecular research has faced a core challenge: it can generate countless new molecules through algorithms but struggles to implement them efficiently in real-world production. MetaNovas's key breakthrough lies in its Agentic AI R&D System:

Full-Chain Integration: Moving beyond the mindset of focusing on single technical points, it has achieved a critical leap from "AI-designed molecules" to "AI-implemented molecules."

Compliance and Registration: Currently, the new molecules designed by its AI have successfully completed the entire process from laboratory research to application in the consumer market, and have also completed global new material compliance registration.

Capitalizing on the Consumer Health Market: Top Brands in China and the U.S. Have Already Joined In

Unlike many AI projects that are still at the theoretical stage, MetaNovas's technology has already been deeply integrated into our daily lives.

Implementation Results: Its self-developed new molecules have successfully entered the supply chains of leading brands in cosmetics and medical devices in both China and the United States.

Industrial Empowerment: Through the empowerment of Agentic AI, brand owners can significantly shorten the development cycle of new ingredients and accurately capture niche demands in the consumer health market.

Investor Confidence: The "Super Agent" of New Material Innovation

This round of financing will be primarily used to deepen technological R&D and industrial layout. As Shanghai Yuanxin Zhiyao Technology Co., Ltd. (a related entity of MetaNovas) continues to drive innovation in materials through AI, the industry is beginning to see a new possibility: AI is no longer just an assistant to scientists, but rather a "super agent" capable of completing the entire cycle from discovery to implementation independently.